Latest News

June 2021

The Cambridge Biomedical Campus will double in size in the next 20 years if the new vision published by its occupiers - including Cambridge University, AstraZeneca, and Addenbrooke's - is realised:


With India battling a shortage of Liposomal Amphotericin B to treat Mucormycosis (black fungus), Hyderabad-based specialty biopharma player Celon Laboratories has developed an alternative emulsion-based Amphotericin B injection:


Wide ethnic and gender representation in clinical trials are extremely important, leading directly to better data and hence advice given by regulators, trust in health authorities, and uptake in vaccinations:


Reportlinker.com announces the release of the report "Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market". The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, and estimates growth patterns for the next five years:


America’s National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens:


In this resource, you can track COVID-19 vaccines advancing through clinical trials, including efficacy data and side effects of approved vaccines, as well as progress on new candidates entering human studies:


US lawmakers are proposing a bill to jumpstart Covid-disrupted clinical trials. The Loans for Biomedical Research Act would provide funding to clinical trials researching treatments for unmet medical needs:


The world’s first Alzheimer’s disease (AD)) drug candidate designed by artificial intelligence will soon enter a first-in-human Phase I clinical trial in the US. The study will assess whether DSP-0038 has improved antipsychotic effects in patients with AD psychosis:


The potential of repurposed drugs targeting COVID-19 - The Montreal Heart Institute’s COLCORONA Study results published in The Lancet reveal promise with the gout drug Colchicine:


Consideration has to be given to extending Covid vaccine shelf-life as African nations including Malawi and the DRC have been given doses without enough time to complete distribution before expiry dates kick in:



Oracle Partner NCC Group

Customer Area